98
Views
13
CrossRef citations to date
0
Altmetric
Review

Prophylactic antibiotics in obstetrics–gynecology: a current asset, a future liability?

Pages 957-964 | Published online: 10 Jan 2014

References

  • Petersdorf RG, Curtin JA, Hoeprich PD et al. A study of antibiotic prophylaxis in unconscious patients. N. Engl. J. Med.257, 1001–1009 (1957).
  • Karl RC, Merte JJ, Veith FJ et al. Prophylactic antimicrobial drugs in surgery. N. Engl. J. Med.275, 305–308 (1966).
  • Burke JF. The effective period of preventive antibiotic action in experimental incision and dermal lesions. Surgery50, 161–168 (1961).
  • Bernard HR, Lok WR. The prophylaxis of surgical infection: the effect of prophylactic antimicrobial drugs on the incidence of infection following potentially contaminated operations. Surgery56, 151–157 (1964).
  • Polk H, Lopez-Mayor J. Post-operative wound infection: a prophylactic study of determinant factors and prevention. Surgery66, 97–102 (1969).
  • Ledger WJ, Gee C, Lewis W. Guidelines for antibiotic prophylaxis in gynecology. Am. J. Obstet. Gynecol.121, 1038–1045 (1975).
  • Bartlett JG, Onderdonk AB, Drude E et al. Quantitative bacteriology of the vaginal flora. J. Infect. Dis.136, 271 (1977).
  • Gorbach SL, Menda KB, Thadepalli H et al. Anaerobic microflora of the cervix in healthy women. Am. J. Obstet. Gynecol.117, 1053–1055 (1973).
  • Hyman RW, Fukushima M, Diamond L et al. PNAS102, 7952–7957 (2005).
  • Schwebke JR, Richey CM, Weiss HL. Correlations of behaviors with microbiologic changes in vaginal flora. J. Infect. Dis.180, 1632–1636 (1999).
  • Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factor for cuff cellulitis after abdominal hysterectomy. Am. J. Obstet. Gynecol.163, 1016–1023 (1990).
  • Watts H, Krohn MA, Hillier SL et al. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet. Gynecol.75, 52–58 (1990).
  • Donders GGG, Vereecken A, Bosmans E et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Br. J. Obstet. Gynecol.109, 1–10 (2002).
  • Burkman RT, Tonascia JA, Atienza MF et al. Untreated endocervical gonorrhea and endometritis following elective abortion. Am. J. Obstet. Gynecol.126, 648–651 (1976).
  • Moller BR, Ahrens S, Laurin J et al. Pelvic infection after elective abortion associated with Chlamydia trachomatis. Obstet. Gynecol.59, 210–213 (1982).
  • Wells CL, Jechorek RP, Twiggs LB et al. Recovery of viable bacteria from pelvic lymph nodes of patients with gynecologic tumors. J. Infect. Dis.162, 1216–1218 (1990).
  • Miller JM Jr, Popkin MJ, Hill GB. Bacterial colonization of amniotic fluid from intact fetal membranes. Am. J. Obstet. Gynecol.136, 796–804 (1980).
  • Chelmow D, Ruehli MS, Huang E. Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: a meta-analysis. Am. J. Obstet. Gynecol.184, 656–661 (2001).
  • Platt R, Zalenik DF, Hopkins CC et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N. Engl. J. Med.322, 153–160 (1990).
  • DiZerega G, Yonekura L et al. A comparison of clindamycin-gentamicin and penicillin-gentamicin in the treatment of post-cesarean section endomyometritis. Am. J. Obstet. Gynecol.134, 238 (1979).
  • Hamod KA, Spence MR, Rosenshein et al. Single-dose and multidose prophylaxis in vaginal hysterectomy: a comparison of sodium cephalothin and metronidazole. Am. J. Obstet. Gynecol.136, 976–979 (1980).
  • Ledger WJ, Sweet RL, Headington JT. Prophylactic cephalordine in the treatment of post-operative pelvic infection in premenopausal women undergoing vaginal hysterectomy. Am. J. Obstet. Gynecol.115, 766–774 (1973).
  • Micha JP, Kucera PR, Birkett JP et al. Prophylactic mezlocillin in radical hysterectomy. Obstet. Gynecol.69, 251–254 (1987).
  • Wong R, Gee CL, Ledger WJ. Prophylactic use of cefazolin in monitored obstetric patients undergoing cesarean section. Obstet. Gynecol.51, 407–411 (1978).
  • Sawaya GF, Grady O, Kerlikouske K et al. Antibiotics at the time of induced abortions: the case for universal prophylaxis based on a meta-analysis. Obstet. Gynecol.87, 884–890 (1996).
  • Pittaway DE, Winfield AC, Maxson W et al. Prevention of acute pelvic inflammatory disease after hysterosalpingography: efficacy of doxycycline prophylaxis. Am. J. Obstet. Gynecol.147, 623–626 (1983).
  • Sinei SKA, Schulz KF, Lamptey PR et al. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br. J. Obstet. Gynecol.97, 412–419 (1990).
  • Mittendorf R, Aronson MP, Berry RE et al. Avoiding serious infections with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am. J. Obstet. Gynecol.169, 1119–1124 (1993).
  • Berkeley AS, Hayworth SD, Hirsch JC et al. Controlled comparative study of moxalactam and cefazolin for prophylaxis of abdominal hysterectomy. Surg. Gynecol. Obstet.161, 457–461 (1985).
  • Tanos V, Rojansky N. Prophylactic antibiotics in abdominal hysterectomy. J. Am. Coll. Surg.179, 593–600 (1994).
  • Nahum GG, Uhl K, Kennedy DL. Antibiotic use in pregnancy and lactation. Obstet. Gynecol.107, 1120–1138 (2006).
  • Cunningham FG, Leveno KJ, De Palma RT et al. Perioperative antimicrobials for cesarean delivery: before or after cord clamping? Obstet. Gynecol.62, 151–154 (1983).
  • Gordon HR, Phelps D, Blanchard K. Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstet. Gynecol.53, 151–156 (1979).
  • Shapiro M, Munoz A, Tager IB et al. Risk factors for infection in the operative site after abdominal or vaginal hysterectomy. N. Engl. J. Med.307, 1661–1666 (1982).
  • Berkeley SA, Freedman SK, Ledger WJ et al. Comparison of cefotetan and cefoxitin prophylaxis for abdominal and vaginal hysterectomy. Am. J. Obstet. Gynecol.158, 706–709 (1988).
  • Hemsell DL, Heard ML, Nobles BJ et al. Single-dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hystectomy. Obstet. Gynecol.63, 285–290 (1984).
  • Price DJE, Sleigh JD. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet2, 1213–1215 (1980).
  • Blackwell AL, Emery SJ, Thomas PD et al. Universal prophylaxis for Chlamydia trachomatis and anaerobic vaginosis in women attending for suction termination of pregnancy: an audit of short-term health gains. Int. J. STD AIDS10, 508–513 (1999).
  • Genç M, Mardh P-A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann. Inter. Med.1241–1247 (1996).
  • Rehu M, Jahkola M. Prophylactic antibiotics in cesarean section: effect of a short pre-operative course of benzyl penicillin or clindamycin plus gentamicin on post-operative infectious morbidity. Ann. Clin. Res.12, 45–48 (1980).
  • Faro S, Martens MG, Hammill HA et al. Antibiotic prophylaxis: is there a difference? Am. J. Obstet. Gynecol.162, 900–909 (1990).
  • Hemsell DL, Johnson ER, Heard MC et al. Single-dose piperacillin versus triple dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. South Med. J.82, 438–442 (1989).
  • Culver DH, Horan TC, Gaynes RP et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am. J. Med.91, S152–S157 (1991).
  • Zangwill KM, Schuchat A, Wenger JD. Group B Streptococcus disease in the United States, 1990: report from multistage active surveillance system. Morb. Mortal Wkly. Rep.41, 25–32 (1992).
  • Yow MD, Mason ED, Leeds LJ et al. Ampicillin prevents intrapartum chemoprophylaxis of neonatal Group B streptococcal early-onset disease III. Interruption of mother-to-infant transmission. J. Infect. Dis.148, 810–816 (1983).
  • Boyer KM, Gadzala CA, Kelly PD et al. Selective intrapartum chemoprophylaxis of neonatal Group B streptococcal early-onset disease III. Interruption of mother to infant transmission. J. Infect. Dis.148, 810–816 (1983).
  • Centers for Disease Control and Prevention. Prevention of group B streptococcal disease: a public health perspective. MMWR45(RR–7), 1–24 (1996).
  • Ledger WJ. CDC guidelines for the prevention of perinatal group B streptococcal disease: are they appropriate? Inf. Dis. Clin. Pract.7, 188–193 (1998).
  • Ramos RM, McIntire DD, Wendel GD Jr. Antibiotic chemoprophylaxis for group B strep is not necessary with elective cesarean section. Am. J. Obstet. Gynecol.180, S85 (1999).
  • Hager WD, Schuchat A, Gibbs R et al. Prevention of perinatal group B streptococcal infection: current controversies. Obstet. Gynecol.96, 141–145 (2000).
  • Schrag SJ, Zell ER, Lynfield R et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N. Engl. J. Med.347, 233–239 (2002).
  • Centers for Disease Control and Prevention. Prevention of group B streptococcal disease: revised guidelines from CDC. MMWR51(RR-11), 1–24 (2002).
  • Stray-Pedersen B, Bergan T, Hafstad A et al. Vaginal disinfection with chlorhexidine during childbirth. Intl. J. Antimicrob. Agents12, 245–251 (1999).
  • Nichols RL, Broido P, Condon RE et al. The effect of preoperative neomycin erythromycin intestinal preparation on the incidence of infectious complications following colon surgery. Am. Surg.178, 453–462 (1973).
  • Rouse DJ, Hauth JC, Andrews WW et al. Chlorhexidine vaginal irrigation for the prevention of peripartal infection: a placebo-controlled randomized clinical trial. Am. J. Obstet. Gynecol.176, 617–622 (1997).
  • Dinsmore MJ, Viloria R, Lief L et al. Use of intrapartum antibiotics and the incidence of postnatal maternal and neonatal yeast infections. Obstet. Gynecol.106, 19–22 (2005).
  • Towers CV, Carr MH, Padilla G et al. Potential consequences of widespread antepartal use of ampicillin. Am. J. Obstet. Gynecol.179, 879–883 (1998).
  • Mayor-Lynn K, Gonzalez-Quintero VH, O’Sullivan MJ et al. Comparison of early onset neonatal sepsis caused by Escherichia coli and group B Streptococcus. Am. J. Obstet. Gynecol.192, 1437–1439 (2005).
  • Stoll BJ, Hansen Fanaroff AA et al. Changes in pathogen causing early-onset sepsis in very low birth weight infants. N. Engl. J. Med.347, 240–247 (2002).
  • Mercer B, Miodovnik M, Thurnau G et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of membranes. A randominzed controlled trial. JAMA278, 989–995 (1997).
  • Kenyon SL, Taylor DJ, Tarnow-Mordi W et al. Broad spectrum antibiotics for preterm prelabor rupture of fetal membranes. The Oracle I randomized trial. Lancet357, 979–988 (2001).
  • Fridkin SK, Hageman JC, Morrison M et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med.352, 1436–1444 (2005).
  • Hammill H, Tiran J. CAMRSA the new women’s health epidemic. A review of eight recent cases of community-acquired MRSA infections in women. International Infectious Disease Society for Obstetrics and Gynecology-USA. 11th Annual Conference on Women’s Health Care Issues. Alexandria, Virginia 5 May (2006).
  • Aroutcheva A, Rice T, Welbel MA et al. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in pregnant and post-partum women and premature newborns. Abstract. International Infectious Disease Society for Obstetrics and Gynecology-USA. 11th Annual Conference on Women’s Health Care Issues. Alexandria, Virginia 5 May (2006).
  • Eliopoulos GM. Issues with glycopeptides in the treatment of serious Gram-positive infections. Part III review of current treatment options to manage serious Gram-positive infections. Clin. Updates Inf. Dis.8, 1–6 (2006).
  • Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin. Infect. Dis.37, 1496–1505 (2003).
  • Warny M, Pepin T, Fang A et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet366, 1079–1084 (2005).
  • Wren SM, Ahmed N, Jamal A et al. Preoperative oral antibiotics in colorectal surgery increase the rate of Clostridium difficile colitis. Arch. Surg.752–756 (2005).
  • Mercer B, Hrodovnik N, Thurnau GR et al. Antiobiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. JAMA278, 989–995 (1997).
  • Beazley D. Impact of amnionitis and antibiotic treatment on neonatal outcome after PPROM. Am. J. Obstet. Gynecol.S15 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.